Search the Newsreel

Northrop Grumman (NOC) Raises 2026 Guidance, Is The Stock Still Cheap?

REG - BlackRock Group Gamma Communications - Form 8.3 - Gamma Communications plc

Man Group PLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Man Group PLC (b) Owner or …

Advanced Flower Capital Inc. Revenue Breakdown – NASDAQ:AFCG

Northrop Grumman Corporation Revenue Breakdown – NYSE:NOC

IMTX|Immatics NV|Price:8.660|Chg%:-0.540

This article provides an in-depth analysis of Immatics NV (IMTX) stock, including real-time quotes, key financial figures, and market trends. It highlights the company's strong fundamentals, high growth potential, and "Strong Buy" analyst ratings with significant upside potential. The report also details Immatics NV's …

Northrop Grumman (NYSE:NOC): A Dividend Quality Pick for Income Investors

Northrop Grumman (NYSE:NOC) is highlighted as a quality dividend pick for income investors, passing ChartMill's "Best Dividend" screen. The company boasts a strong dividend history, robust profitability metrics, and a conservative payout ratio, despite some caution advised regarding its health rating and dividend growth …

Bannari Amman Spinning Mills Ltd (NSE:BASML) Is About To Go Ex-Dividend, And It Pays A 0.9% Yield

Immatics NV (IMTX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Immatics NV (IMTX), noting its current valuation score of 6.90 within the Biotechnology & Medical Research industry. It highlights the company's current P/E ratio of -12.17, which is significantly below its recent high and above its recent …

Northrop Grumman (NOC) Stock Looks Undervalued Despite 62% Gains And Budget Risk

Northrop Grumman (NOC) stock appears undervalued based on both Discounted Cash Flow (DCF) estimates and P/E ratio analysis, despite its 62.4% gain over the past five years. The company's strong contract backlog and recent Q2 results support a positive outlook, though budget and execution …

Following Half Year Earnings Is Hermès International (ENXTPA:RMS) Valuation Now Fully Valued?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Hermès International earnings put recent share performance in focus Hermès International Société en commandite par actions (ENXTPA:RMS) reported half year 2026 earnings with sales of …

Northrop Grumman to integrate SATURN anti-jam communications into E-2D Advanced Hawkeye

The U.S. Navy awarded Northrop Grumman Systems Corp. a $21.1 million contract to integrate SATURN (Second Generation Anti-jam Tactical Ultra High Frequency Radio) anti-jam communications into its E-2D Advanced Hawkeye fleet. This contract includes engineering, software development, avionics modifications, and the production of 94 …

Immatics Number of Employees 2026 | Employee Count & Headcount Data

Immatics NV (NASDAQ: IMTX) had 426 employees worldwide as of March 2026, representing a 54.3% growth from 2023. The company, headquartered in Germany, is actively hiring with 45 job postings in 2026 and its workforce is primarily concentrated in Germany and the United States. …

Immatics (IMTX) general counsel Pepin Nelson reports insider status

Immatics N.V. (IMTX) general counsel and corporate secretary Pepin James Nelson has filed an initial statement of beneficial ownership (Form 3), establishing his insider status. The filing indicates no reported equity or derivative transactions, classifying him as an officer-reporting person. The document also notes …

Here’s What Rising Defense Spending Means for Northrop Grumman (NOC)

Northrop Grumman Corp (NYSE:NOC)'s leadership in military aviation received another boost after the U.S. Navy awarded the company a $1.2 billion contract. The award reinforces the company's growing backlog and highlights why rising global defense spending continues to strengthen its long-term investment case. The …

Northrop Grumman Corporation $NOC Position Reduced by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership significantly reduced its stake in Northrop Grumman Corporation by 62.9% in the first quarter, selling 86,061 shares. Despite this reduction, other institutional investors like Capital World Investors and J. Stern & Co. LLP increased their holdings. Northrop Grumman recently topped …

Al-Moammar Information Systems Company Announces Project Award with King Saud Medical City for Sar 179,784,553.10 Including Vat

Immatics NV (IMTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Immatics NV (IMTX), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. As of the analysis, the stock trades between support at 7.64 and resistance at 10.36, with a current price …

NOC|Northrop Grumman Corp|Price:547.230|Chg%:+4.990

This article provides a comprehensive stock analysis of Northrop Grumman Corp (NOC) by TradingKey, highlighting its stable fundamentals, high growth potential, and fair valuation within the Aerospace & Defense industry. The company boasts high profit growth, a stable dividend, and a very high institutional …

Immatics N.V. (NASDAQ:IMTX) Given Consensus Rating of "Moderate Buy" by Analysts

Eight analysts covering Immatics N.V. (NASDAQ:IMTX) have issued a "Moderate Buy" consensus rating, with six recommending a buy, one a hold, and one a sell. The average 12-month price target is $20.80, significantly above the current $9.08 share price, and institutional investors own 64.41% …

Troluce Capital Advisors LLC Acquires Shares of 250,000 Immatics N.V. $IMTX

Troluce Capital Advisors LLC recently acquired 250,000 shares of Immatics N.V. (NASDAQ:IMTX) for approximately $2.46 million, establishing a new position in the company. Despite Immatics missing Q1 analyst estimates for revenue and EPS, and receiving mixed analyst ratings with some recent downgrades, the consensus …

IMTX|Immatics NV|Price:8.800|

This article from TradingKey provides a comprehensive stock analysis of Immatics NV (IMTX), highlighting its strong fundamentals, significant growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. It notes high institutional ownership and multiple "Buy" ratings from analysts, despite a …

Why Did Northrop Grumman (NOC) Fall After Raising Its 2026 Forecast?

Northrop Grumman Corporation (NYSE:NOC) beat quarterly expectations, secured $20 billion in net awards, reported record backlog, and raised its 2026 sales and MTM-adjusted earnings forecasts. Yet the shares closed 2.23% lower at $512.29 on July 21. The contradiction becomes clearer when the quality of …

Sei Investments Co. Sells 7,571 Shares of Northrop Grumman Corporation $NOC

Sei Investments Co. reduced its stake in Northrop Grumman Corporation by 10.7% in the first quarter, selling 7,571 shares, while other institutional investors like Capital World Investors and J. Stern & Co. LLP significantly increased their holdings. Northrop Grumman recently exceeded Q2 earnings expectations, …

Immatics NV (IMTX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Immatics NV (IMTX), listing its major shareholders and their proportional holdings. It also provides a breakdown of shareholder types, institutional shareholding data over several quarters, and recent shareholder activity from key investors. Additionally, the article identifies related …

Clough Capital Partners L P Sells 3,486 Shares of Northrop Grumman Corporation $NOC

Clough Capital Partners L P reduced its stake in Northrop Grumman Corporation by 22.8% in the first quarter, selling 3,486 shares and owning 11,830 shares valued at $8.071 million. Despite this reduction, other institutional investors increased their holdings, with Vanguard Group Inc. being the …

Immatics NV (IMTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Immatics NV (IMTX). It indicates that the company has not distributed any dividends over the past five years. The page displays various financial metrics for IMTX, including its market capitalization, and stock …

Immatics NV (IMTX) Cash Flow

This article provides a detailed cash flow statement for Immatics NV (IMTX), broken down by operating, investing, and financing activities on both quarterly and annual bases. It includes financial figures, year-over-year changes, and a section of FAQs defining cash flow terms and summarizing Immatics …

Immatics N.V. Revenue Breakdown – NASDAQ:IMTX

Immatics N.V. (NASDAQ:IMTX) reported a revenue of $56.73 million USD last year. The majority of this revenue, $54.47 million USD, was generated by its PRAME-directed Immunotherapies segment, primarily from the United States. This represents a significant decrease compared to the previous year's total revenue …

Themes Management Co LLC Buys 2,832 Shares of Northrop Grumman Corporation $NOC

Themes Management Co LLC increased its stake in Northrop Grumman Corporation by 67.2% during the first quarter, purchasing an additional 2,832 shares. This acquisition brings their total holdings to 7,046 shares, valued at $4,807,000, making Northrop Grumman its fifth-largest position. Other institutional investors like …

Northrop Grumman Corp (NOC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Northrop Grumman Corp (NOC), highlighting its major institutional investors and their respective holdings. Key information includes the top institutional shareholders, a breakdown of shareholder types, and historical institutional shareholding data over several quarters. It also lists related …

IMTX|Immatics NV|Price:9.080|Chg%:-0.210

Immatics NV is a Netherlands-based clinical-stage biopharmaceutical company focused on developing T-Cell receptor immunotherapies for solid tumors. The company employs two therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER), with several programs in clinical trials and preclinical development. Its executive team …

TradingKey

This article provides a detailed quarterly and annual income statement for Immatics NV (IMTX), offering insights into the company's financial performance and operational efficiency. It presents data spanning several years for various financial metrics such as total revenue, operating expenses, net income, and earnings …

SpaceX (SPCX) Launches Northrop Grumman Repair Mission And Opens A New Service Market

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Space Exploration Technologies (NasdaqGS:SPCX) launched Northrop Grumman's MRV-MEP satellite repair mission, focused on on-orbit …

Is Northrop Grumman (NOC) Still Below Fair Value Following Raised Sales Guidance?

Northrop Grumman (NOC) recently reported strong quarterly earnings and raised its full-year sales guidance, driven by new contract awards and a significant backlog. Despite a recent share price jump and a 7.41% year-to-date decline, the stock is considered 19.1% undervalued by Simply Wall St, …

Northrop Grumman (NOC) shareholder plans NYSE sale of equity-comp stock

A Northrop Grumman (NOC) shareholder has filed a Form 144 to sell common stock on or after July 22, 2026, through Merrill Lynch on the NYSE. The shares originated from equity compensation grants issued between 2015 and 2026, including a notable block of 4,304 …

Form 144 Northrop Grumman Corp For: 24 July By Investing.com

This article briefly reports on a Form 144 filing by Northrop Grumman Corp for July 24. A Form 144 indicates an intent to sell restricted securities, which can sometimes be insider selling. The article provides minimal detail beyond the filing itself and the date.